Stockscreener 앱 받기
35.29
0.14%
-0.05
전일 마감가:
$35.34
열려 있는:
$35.51
하루 거래량:
434.68K
Relative Volume:
0.86
시가총액:
$1.77B
수익:
$226.84M
순이익/손실:
$3.55M
주가수익비율:
504.14
EPS:
0.07
순현금흐름:
$-12.02M
1주 성능:
-11.38%
1개월 성능:
-16.02%
6개월 성능:
-40.75%
1년 성능:
-29.57%
1일 변동 폭
$34.87
$36.05
1주일 범위
$34.87
$39.95
52주 변동 폭
$34.87
$63.00
베리셀 Stock (VCEL) Company Profile
명칭
Vericel Corp
전화
(734) 930-5555
주소
64 SIDNEY ST., CAMBRIDGE, MA
VCEL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
35.26 | 2.00B | 226.84M | 3.55M | -12.02M | 0.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
546.62 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.88 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
565.90 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
290.69 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
베리셀 Stock (VCEL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-09 | 개시 | Canaccord Genuity | Buy |
| 2024-06-20 | 개시 | TD Cowen | Buy |
| 2024-01-25 | 업그레이드 | Truist | Hold → Buy |
| 2023-08-08 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-11-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-11-09 | 다운그레이드 | Truist | Buy → Hold |
| 2022-10-14 | 재개 | Stephens | Overweight |
| 2021-01-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-12-18 | 개시 | Stephens | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2019-10-09 | 개시 | H.C. Wainwright | Buy |
| 2019-02-28 | 다운그레이드 | Needham | Buy → Hold |
| 2018-08-08 | 재확인 | Needham | Buy |
| 2018-07-16 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2018-04-04 | 개시 | Leerink Partners | Outperform |
| 2018-03-06 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2018-03-06 | 재확인 | Needham | Buy |
| 2018-03-05 | 재확인 | BTIG Research | Buy |
| 2017-06-21 | 개시 | BTIG Research | Buy |
| 2017-03-13 | 재확인 | Needham | Buy |
| 2016-12-22 | 개시 | Piper Jaffray | Overweight |
| 2016-11-09 | 재확인 | Needham | Buy |
| 2016-04-05 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2016-03-11 | 업그레이드 | Needham | Hold → Buy |
모두보기
베리셀 주식(VCEL)의 최신 뉴스
Bank of New York Mellon Corp Sells 9,409 Shares of Vericel Corporation (NASDAQ:VCEL) - Defense World
What drives Vericel Corporation stock priceFree Expert Stock Watchlist - Autocar Professional
Nisa Investment Advisors LLC Sells 315 Shares of Vericel Corporation (NASDAQ:VCEL) - Defense World
Cerity Partners LLC Boosts Position in Vericel Corporation (NASDAQ:VCEL) - Defense World
Is Vericel Corporation a good long term investmentFastest-growing stock picks - Jammu Links News
Is Vericel Corporation stock overhyped or has real potential2x 3x 5x Pick Alert - Newser
How high can Vericel Corporation stock price go in 20252x Return Forecast - Newser
What institutions are buying Vericel Corporation stock nowVerified Return Tips - newser.com
Vericel Corporation to Report Second-Quarter 2025 Financial Results on July 31, 2025 - Quiver Quantitative
Advanced Therapy Leader Vericel Sets Q2 2025 Earnings Release DateKey Details for Investors - Stock Titan
Vericel Corporation (NASDAQ:VCEL) Shares Sold by Teacher Retirement System of Texas - Defense World
Vericel stock hits 52-week low at $37.38 amid market challenges - Investing.com Nigeria
Vericel stock hits 52-week low at $37.38 amid market challenges By Investing.com - Investing.com South Africa
What makes Vericel Corporation stock price move sharplyFree Stock Movement Tracking - Newser
Why Vericel Corporation stock attracts strong analyst attentionReal Trader Insights - Newser
Vericel stock maintains Buy rating at BTIG despite potential competition - Investing.com
Principal Financial Group Inc. Buys 7,222 Shares of Vericel Corporation (NASDAQ:VCEL) - Defense World
Amalgamated Bank Reduces Position in Vericel Corporation (NASDAQ:VCEL) - Defense World
New York State Teachers Retirement System Decreases Stock Position in Vericel Corporation (NASDAQ:VCEL) - Defense World
GAMMA Investing LLC Has $129,000 Holdings in Vericel Corporation (NASDAQ:VCEL) - Defense World
Vericel Corporation (NASDAQ:VCEL) Receives $61.14 Consensus Price Target from Analysts - Defense World
Vericel Corporation(NasdaqGM: VCEL) added to Russell 2000 Defensive Index - MarketScreener
Is Vericel Corp. overvalued or undervalued? - MarketsMojo
If EPS Growth Is Important To You, Vericel (NASDAQ:VCEL) Presents An Opportunity - Yahoo Finance
Vericel at 2025 Truist Securities MedTech Conference: Growth Strategies Unveiled - Investing.com India
Vericel (NASDAQ:VCEL) Given “Overweight” Rating at Stephens - Defense World
Vericel (VCEL): Analyst Reiterates Overweight Rating with Stable Price Target | VCEL Stock News - GuruFocus
Handelsbanken Fonder AB Has $914,000 Holdings in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel Co. (NASDAQ:VCEL) Shares Sold by Rhumbline Advisers - Defense World
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025 - Yahoo Finance
GAMMA Investing LLC Acquires 127,028 Shares of Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel Co. (NASDAQ:VCEL) Given Average Recommendation of “Buy” by Analysts - Defense World
3,924 Shares in Vericel Co. (NASDAQ:VCEL) Bought by Mackenzie Financial Corp - Defense World
Canaccord Genuity reiterates Buy rating on Vericel stock with $61 target - Investing.com
Bank of America Corp DE Sells 1,579 Shares of Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel’s (VCEL) Overweight Rating Reiterated at Stephens - Defense World
What Analysts Are Saying About Vericel Stock - Benzinga
Vericel (VCEL) Maintains Overweight Rating by Stephens & Co. | V - GuruFocus
Vericel Co. (NASDAQ:VCEL) Shares Purchased by Deutsche Bank AG - Defense World
Vericel Co. (NASDAQ:VCEL) Stock Position Cut by BNP Paribas Financial Markets - Defense World
Truist maintains Buy on Vericel shares with $52 target By Investing.com - Investing.com India
Truist maintains Buy on Vericel shares with $52 target - Investing.com
VCEL to Be Featured in Upcoming Investor Meetings | VCEL Stock N - GuruFocus
Brokerages Set Vericel Co. (NASDAQ:VCEL) Price Target at $60.86 - Defense World
Vericel at BofA Securities Conference: Growth and Innovation in Healthcare By Investing.com - Investing.com India
Vericel at BofA Securities Conference: Growth and Innovation in Healthcare - Investing.com Australia
Transcript : Vericel Corporation Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 09 - marketscreener.com
베리셀 (VCEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.03%
0.17%
자본화:
|
볼륨(24시간):